Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid...

Chargel, the first-of-its-kind, pocket sized and easy to consume athletic Gel Drink, is kicking off the 2023 racing season onsite at the Los Angeles Marathon Expo. Athletes and spectators alike...

Of the 67 new Fellows of the American Academy of Hospice and Palliative Medicine, or FAAHPM, VITAS Healthcare is proud to be the employer of three: Agron Ismaili, MD, MBA, FACP, FAAHPM, FASAM,...

Leading water heater and boiler manufacturer will highlight its reliable, ENERGY STAR®-certified products at annual Restaurant Facility Management Association event in San Antonio in March...

With sustainability at its core, TENCEL™, the textile fiber brand under Lenzing, is committed to providing innovative fiber solutions that drive industry-wide circularity and transparency,...

Actively targets the automobile/power generation market with hydrogen fuel cell core products Introduces membrane material-based item 'Vent' and seeks new applications TOKYO and SEOUL, South...

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced an...

Poster presentations provide data on Replicate's lead immuno-oncology candidate, RBI-1000, in targeting acquired resistance mutations and on another proof-of-concept study demonstrating the...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that an abstract highlighting pre-clinical data for CRB-601, its...

- Company plans to highlight preclinical proof-of-concept data for EO-3021 in an oral presentation at the New Drugs on the Horizon special session NEW YORK, March 14, 2023 /PRNewswire/ --...